Two new AI science assistants, Google's Co-Scientist and FutureHouse's system, demonstrate success in drug retargeting by helping researchers process vast amounts of scientific literature and biological data. Both systems operate as 'agentic' tools that work in the background, with Google's approach involving human oversight while FutureHouse's system can evaluate specific biological experiment data. While not replacing scientists, these tools address the challenge of information overload in scientific research by identifying potential drug applications across different fields.
Background
The rapid growth of scientific publications has made it increasingly difficult for researchers to stay current with all relevant literature in their field, let alone discover cross-disciplinary connections. AI tools are being developed to help scientists process and analyze this overwhelming amount of information more efficiently.
- Source
- Ars Technica
- Published
- May 20, 2026 at 02:55 AM
- Score
- 7.0 / 10